Drug delivery device, method of manufacture, and method of use

Patent metadata

Field	Value
Publication number	US-12433994-B2
Application number	US-202217688578-A
Country	US
Kind code	B2
Filing date	Mar 7, 2022
Priority date	Feb 12, 2016
Publication date	Oct 7, 2025
Grant date	Oct 7, 2025

Abstract

Disclosed herein is a wearable drug delivery device including a container filled at least partially with a drug including at least one of a PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) specific antibody, a granulocyte colony-stimulating factor (G-CSF), a sclerostin antibody, or a calcitonin gene-related peptide (CGRP) antibody. The wearable drug delivery device may include a needle and an insertion mechanism configured to insert the needle into a patient. A fluid pathway connector may define a sterile fluid flowpath between the container and the insertion mechanism. Optionally, a cannula initially disposed about the needle may be included. The cannula may be retained in the patient at an injection site created by the needle after the needle is withdrawn from the patient. Methods of assembly and operation are also provided.

First claim

What is claimed is:

1. A wearable drug delivery device comprising:
a housing;
a container disposed at least partially within the housing;
a first seal at least partially covering an opening formed in a wall of the container;
a plunger seal moveably disposed within the container;
a drug disposed within the container, the drug comprising at least one of a granulocyte colony-stimulating factor (G-CSF) or a Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) specific antibody;
a drive mechanism configured to move the plunger seal through the container to expel the drug from the container;
a needle having at least: a first position wherein a point of the needle is not disposed through a surface of the first seal, and a second position wherein the point of the needle is disposed through the surface of the first seal into the container;
an insertion mechanism disposed at least partially within the housing, wherein the insertion mechanism comprises:
a rotational biasing member configured to rotate the insertion mechanism housing,
a delivery member connected or configured to be connected in fluid communication with the container, the delivery member being moveable between a first position wherein an insertion portion of the delivery member is positioned within the housing and a second position wherein the insertion portion of the delivery member is positioned exterior to the housing for insertion into a patient,
a hub operably coupled with the delivery member, and
wherein the insertion mechanism housing is operably coupled with the hub such that initial rotation of the insertion mechanism housing causes the delivery member to move axially from the first position to the second position;

an ultraviolet (UV) light source; and
wherein at least a portion of the wearable drug delivery device is configured to facilitate UV sterilization of at least a portion of the surface of the first seal.

2. The wearable drug delivery device of claim 1 , wherein the UV light source is disposed at least partially within the housing.

3. The wearable drug delivery device of claim 1 , wherein the insertion mechanism housing comprises a cylindrical portion and at least a portion of the delivery member is positioned within the cylindrical portion when the delivery member is in the first position.

4. The wearable drug delivery device of claim 1 , wherein the insertion mechanism housing comprises a first guide surface and the hub comprises an outwardly extending follower configured to slidably engage the first guide surface during rotation of the insertion mechanism housing.

5. The wearable drug delivery device of claim 4 , wherein at least a portion of the first guide surface extends in an axial direction and a circumferential direction.

6. The wearable drug delivery device of claim 4 , comprising a second guide surface fixed rotationally with respect to the housing, wherein the outwardly extending follower is configured to slidably engage the second guide surface to facilitate axial movement of the hub during rotation of the insertion mechanism housing.

7. The wearable drug delivery device of claim 1 , wherein the insertion mechanism housing is rotatable about a rotational axis and the rotational axis is parallel to a longitudinal axis of the delivery member.

8. The wearable drug delivery device of claim 7 , wherein the rotational axis of the insertion mechanism housing is coaxial with the longitudinal axis of the delivery member.

9. The wearable drug delivery device of claim 1 , comprising a first abutment member having a first position wherein the first abutment member engages the insertion mechanism housing to prevent the rotational biasing member from rotating the insertion mechanism housing and second position wherein the first abutment member is disengaged from the insertion mechanism housing to allow the rotational biasing member to rotate the insertion mechanism housing.

10. The wearable drug delivery device of claim 9 , wherein the insertion mechanism housing includes a cylindrical portion and a second abutment member extending outwardly from the cylindrical portion, the second abutment member engaging the first abutment member when the first abutment member is in the first position.

11. The wearable drug delivery device of claim 1 , wherein the drive mechanism is configured to expel the drug from the container and into the patient via the delivery member.

12. The wearable drug delivery device of claim 1 , comprising at least one fluid conduit positioned at least partially in the housing and configured to fluidly connect the delivery member and the container, the at least one fluid conduit being coupled to the hub such that at least a portion of the fluid conduit and the hub translate jointly during insertion of the delivery member into the patient.

13. The wearable drug delivery device of claim 1 , wherein the rotational biasing member comprises a torsion spring.

14. The wearable drug delivery device of claim 1 , wherein the delivery member comprises a second needle.

15. The wearable drug delivery device of claim 14 , wherein the second needle has a hollow interior.

16. The wearable drug delivery device of claim 1 , wherein at least a portion of the rotational biasing member surrounds the insertion mechanism housing.

17. The wearable drug delivery device of claim 16 , wherein the insertion mechanism lacks a cover surrounding the rotational biasing member.

18. The wearable drug delivery device of claim 1 , comprising an adhesive applied to a wall of the housing for removably attaching the housing to skin of a patient.

19. The wearable drug delivery device of claim 18 , comprising an opening formed in the wall of the housing, wherein the insertion portion of the delivery member extends through the opening in the second position.

Assignees

• Amgen Inc

Inventors

• Gibson Scott R
• Moberg Sheldon B
• Taha Basel Hasan
• Boyaval Margaux Frances
• Destefano Mark A
• Love John C
• Hanson Ian B
• Bente Iv Paul F
• Clemente Matthew J
• Ramaswamy Rajan
• Codd Daniel S
• Beaver Scott
• Bokelman Kevin L
• O'Connor Sean M
• Decker Robert
• Shetty Gautam N
• Agard Ryan M
• Ciccarelli Nicholas J
• Davenport Daniel

Classifications

• A61M5/142

  Pressure infusion, e.g. using pumps · CPC title

• A61M2005/14268

  with a reusable and a disposable component · CPC title

• A61M2005/14252

  with needle insertion means · CPC title

• A61M2205/35

  Communication · CPC title

• A61M2205/3368

  Temperature · CPC title